C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CCCC)

CUSIP: 12529R107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 6 signals
Share change
-531,901
SEC-reported price per share
$8.77
Indexed holders
115
Value change
-$2,524,371
Number of buys
64
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
137,921,939

Security key

12529R107

Report period

Q3 2022

Indexed institutions

115

Top holders

10

Ownership snapshot

Top reported holders of CCCC - C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ArrowMark Colorado Holdin...
Disclosed value leader
ArrowMark Colorado Holdin...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F 3/4/5 Highest disclosed value: $44,052,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ArrowMark Colorado Holdings LLC has the largest disclosed position value at $44.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ArrowMark Colorado Holdings LLC's linked filing trail.
Disclosed position value Top 5
ArrowMark Colorado Holdings LLC $44.05M
WASATCH ADVISORS LP $42.73M
PRICE T ROWE ASSOCIATES INC /MD/ $33.05M
BlackRock Finance, Inc. $25.62M
RTW INVESTMENTS, LP $23.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ArrowMark Colorado Holdings LLC
13F
Company
13F
—
denominator unverified
$44,052,000
5,842,407 shares
— 30 Jun 2022
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$42,727,000
5,666,658 shares
— 30 Jun 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$33,049,000
4,383,163 shares
— 30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$25,618,000
3,397,598 shares
— 30 Jun 2022
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$23,335,000
3,094,825 shares
— 30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$14,783,000
1,960,713 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
115
Shares
39,456,577
Indexed holders
115
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 indexed holders
111
Q3 2022 indexed holders
115
Indexed holder difference
4
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .